Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01660958
Other study ID # 00048720
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2012
Est. completion date December 2014

Study information

Verified date August 2019
Source University of Maryland, Baltimore
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Project Grow Smart evaluates the impact fortification with multiple micronutrient powders (MNP) vs. placebo (one vitamin) on child development (primary outcome) and on micronutrient status, growth, and morbidity (secondary outcomes) among young children in rural India (Nalgonda district of Telegana). There is an infant phase and a preschool phase; investigators, study team members, and participants are unaware of whether the fortification is MNP vs. placebo.

The infant phase (enrollment age: 6-14 months) is a 4-cell factorial randomized trial (MNP vs. placebo and early learning vs. routine care), conducted through home visits. Sachets (MNP/placebo) are distributed to be mixed with food. The hypotheses in the infant phase are: 1) MNP leads to better development, growth, and micronutrient status; 2) Early learning leads to better development; 3) Integrated MNP plus early learning leads to better development through both additive and synergistic processes. Developmental evaluations and anthropometric measurements are conducted at baseline, mid-line (6 months), and end-line (12 months). Blood draws for micronutrient status are performed at baseline and endline. Morbidity measures are collected monthly using a morbidity form, modeled after the Demographic and Health Survey.

The preschool phase (enrollment age: 30-48 months) is conducted in Anganwadi Centers (AWC) (preschools). AWC are classified as high or low stimulation, based on an objective observational rating system of the physical environment of the preschools and teacher-child interactions. Preschools are categorized into high/low-quality based on median split, followed by random assignment of MNP/placebo nested within high/low-quality preschools. The hypotheses in the preschool phase are: 1)MNP leads to better development, growth, and micronutrient status; 2) the effect of the MNP on preschoolers' development varies by the quality of the AWC, with stronger effects among preschoolers in high-quality AWCs. The intervention has been modified to coincide with the academic term (September-May). Evaluations are conducted at baseline (September) and end-line (prior to May), with an 8-month intervention period.


Description:

Project Grow Smart has two phases: an infant phase and a preschool phase. The design of the two phases differs, although both evaluate the impact of fortification with multiple micronutrient powders (MNP) vs. placebo on child development.

In the infant phase, 6-14 month old infants are recruited and randomized into one of four cells to receive: placebo, placebo plus early learning, MNP alone, and MNP plus early learning (integrated intervention). Interventions are delivered through biweekly (twice/month) home visits by Village Level Workers. Families of all infants receive information on iron rich foods.

The preschool phase is conducted in 22 Anganwadi Centers (AWC) (i.e., preschools). AWC quality is assessed, based on a 109-item observation scale, organized into 18 categories, based on two validated scales: Early Childhood Environment Rating Scale-Revised (ECERS-R) and HOME Inventory, modified to rate the quality of learning opportunities and teacher-child interactions. After training and establishing inter-rater reliability, two psychologists spend four hours in each preschool and independently complete the observation. Scores are summed and averaged. Based on a median split, preschools are categorized into high/low-quality with random assignment of MNP/placebo nested within high/low-quality preschools. Classifications are unknown by investigators, study team, or preschools.

The preschool protocol has been modified to ensure that the trial coincides with the academic term (September-May) to avoid losing the oldest children who transfer to private or primary schools. Baseline evaluations are conducted in September and end-line evaluations are conducted prior to May. Mid-line evaluations have been eliminated. The intervention is delivered over 8 months. The MNP/placebo was supplied to preschools in identical packets of 200 grams, including two measuring spoons of 1 and 0.5 grams. Each packet includes a manufacturer-assigned alphabetic code. AWC workers mix the MNP/placebo into the first bites of the preschoolers' mid-day meal. Mothers receive information on iron-rich food.


Recruitment information / eligibility

Status Completed
Enrollment 834
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Months to 48 Months
Eligibility Inclusion Criteria:

- Participating children must be in one of two age groups: infants: 6-14 months or preschoolers: 30-48 months, inclusive, at time of recruitment.

- Participants must reside in the Nalgonda district of Telengana, India.

- Preschoolers must attend an Anganwadi Center (preschool) in the Nalgonda district that is participating in Project Grow Smart.

- Participating caregivers must be at least 18 years of age at the time of recruitment.

Exclusion Criteria:

- Children with chronic diseases, developmental disabilities, mental retardation, or severe physical handicaps will be excluded

- Children with severe stunting ( <= -3 standard deviation of length-for-age z-score) or severe anemia (hemoglobin < 7 g/dl) will be excluded and referred to a local hospital for evaluation and intervention, as needed..

Study Design


Intervention

Dietary Supplement:
MNP
The formulation of the multiple micronutrient powder (MNP) was based on low micronutrient intake, low bioavailability of iron and zinc in the Indian diet, and current World Health Organization (WHO)and Indian recommendations regarding fortification and age-specific nutrient requirements. The MNP formulations were produced by a certified company in India and include: Iron, Vitamin A, Vitamin C, Folic Acid, Zinc, Vitamin B12 Vitamin B2, plus filler (maltodextrin). Placebo included riboflavin and maltodextrin.
Behavioral:
Early Learning
• Infant will benefit from interventions that are based on responsive parenting, whereby caregivers respond to children's cues, provide opportunities for exploration, and engage in nurturant and reciprocal communication.

Locations

Country Name City State
India National Institute of Nutrition Hyderabad Andhra Pradesh

Sponsors (4)

Lead Sponsor Collaborator
University of Maryland, Baltimore Indian Council of Medical Research, Micronutrient Initiative, The Mathile Institute for the Advancement of Human Nutrition

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Infants: Change in cognitive, language, motor, and socio-emotional development Data on infants' cognitive, language, motor, and socio-emotional development will be collected at baseline, the 6 month follow-up evaluation, and the 12-month follow-up evaluation using the Mullens Scales of Early Learning. Baseline, Mid-Point (6mo post BL), and End-Point (12mo post BL)
Primary Preschoolers: Change in cognitive, language, motor, and socio-emotional development Data on preschoolers' cognitive, language, motor, and socio-emotional development will be collected at baseline and the 8-month follow-up evaluation using the Mullens Scales of Early Learning. Baseline and End-Point (8mo post BL)
Secondary Infants: Change in micronutrient Status Data on infants' micronutrient status (serum ferritin, transferrin receptor, serum zinc, C-reactive protein) and hemoglobin will be collected at baseline and the 12-month follow-up evaluation. Baseline and End-Point (12 mo post-baseline)
Secondary Preschoolers: Change in micronutrient Status Data on preschoolers' micronutrient status (serum ferritin, transferrin receptor, serum zinc, C-reactive protein) and hemoglobin will be collected at baseline and the 8-month follow-up evaluation. Baseline and End-Point (8mo post BL)
Secondary Infants: Change in weight and height Data on infants' weight and height will be collected at baseline, the 6 month follow-up evaluation, and the 12-month follow-up evaluation Baseline, Mid-Point (6mo post BL), and End-Point (12mo post BL)
Secondary Preschoolers: Change in weight and height Data on preschoolers' weight and height will be collected at baseline and the 8-month follow-up evaluation Baseline and End-Point (8mo post BL)
Secondary Infants: Morbidity Morbidity measures (acute respiratory infection and diarrhea) are conducted monthly using a morbidity form, modeled after the Demographic and Health Survey. Baseline and once a month (for 12mo post BL)
Secondary Preschoolers: Morbidity Morbidity measures (acute respiratory infection and diarrhea) are conducted monthly using a morbidity form, modeled after the Demographic and Health Survey. Baseline and once a month (for 8mo post BL)
See also
  Status Clinical Trial Phase
Completed NCT06052410 - Early Intervention in Children at Risk of Developmental Delay N/A
Not yet recruiting NCT06458959 - Exploratory Trial of a Pediatric Web-Based Care Planning Guide N/A
Recruiting NCT04518332 - Intraoperative Cerebral and Renal Tissue Oxygen Saturation and Pediatric Living Donor Liver Transplantation Prognosis.
Active, not recruiting NCT02000284 - Mitochondrial Dysfunction in Autism Spectrum Disorder
Recruiting NCT05527080 - Development of Motility and Cognition in Infants
Recruiting NCT04672967 - MAP Autism Prediction Study
Completed NCT02712853 - Improving Autism Screening With Brain-Related miRNA
Completed NCT01975506 - Occupational Therapy in the Context of Head Start N/A
Completed NCT01253083 - Mobility Training to Improve Motor Behavior in Toddlers With or at Risk for Cerebral Palsy: A Pilot Study Phase 1
Not yet recruiting NCT05605977 - Home-based Visual-motor Training Program on Kindergarteners N/A
Completed NCT05408351 - The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III
Completed NCT02832557 - A Salivary miRNA Diagnostic Test for Autism
Recruiting NCT02769949 - Pediatric Patients With Metabolic or Other Genetic Disorders
Active, not recruiting NCT02813889 - SmarToyGym: Smart Detection of Atypical Toy-oriented Actions in At-risk Infants N/A
Completed NCT01351077 - CHICA Developmental Screening Study N/A
Completed NCT02115334 - Development and Effectiveness of Home-based Programs for Preschool Children With Developmental Delay N/A
Recruiting NCT06461572 - Effects of Power Ball on Proximal Muscle and Refractive Errors in Developmental Delay. N/A
Suspended NCT03307317 - Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder
Completed NCT03223688 - Early Intervention for Developmental Delay N/A
Completed NCT02141802 - Clinical Effectiveness of Increased Standing Time in Non-ambulant Children With Cerebral Palsy:a Pilot Study N/A